CNS Pharmaceuticals, Inc. CNSP

Where you been this has been on the table since April 15 read their prospectus.

I fully expected this announcement and as reassuring as it is, I believe it’s just shoe #1

The money would have been the same as they have approximately maxed out their current $43M ATM ceiling. Their required shares would have been less is all.

And perhaps it’s a partial buyout ownership play

I like this prospectus and I believe it to be part of a win win strategy for the company and shareholders

Read the 3/31 filing very very closely and the hint is there and should be able to solve the puzzle

Give it the month of April

Quality of life advantage for Berubicin over Lomustine is far from trivial. I see no significant benefit listed for Lomustine superiority over Berubicin. Plus there’s now a reality of proving this drug crosses the BBB which makes it a foundational prospect for future drug combinations which may be the most significant result of all as a proof of concept value to big pharma.

I think we’re only getting half of today’s story designed for the predictable market reaction we’re seeing

No nothins playing for daily lunch money- pathetic!